Smallpox


Risk

  • Declared eradicated worldwide in 1980.

  • Two repositories hold the variola virus: VECTOR in Koltsovo, Novosibirsk, Russia, and the CDC in Atlanta, Georgia, USA.

  • Potential agent of bioterrorism.

  • Vaccinations are not administered to the general public.

    • In 2007, ACAM2000, the newest version of vaccine made of vaccinia virus, became part of the USA stockpile of smallpox vaccines.

Perioperative Risks

  • Hemodynamic compromise from dehydration and/or sepsis

Worry About

  • Facility and provider contamination

Overview

  • Virus enters respiratory tract, migrates into pulmonary lymph nodes, and spreads into the bloodstream.

  • Incubation period is 7–17 d; at this point, not contagious.

  • Prodromal phase is 2–3 d. Abrupt, severe headache, backache, and fever; possibly contagious.

  • Rash develops, increases, and lasts for weeks; this is contagious:

    • Mucous membrane enanthemas, then skin lesions.

    • Centrifugal spread.

    • Starts on extremities and spreads to trunk.

    • Deep-seated, firm, round pustules, leading to rupture and necrosis. leading to scabs.

    • Lesions all in same stage of development.

  • Contagious until resolution of scabs.

  • Approximate 30% mortality; death primarily from sepsis.

  • Must be distinguished from chicken pox (varicella):

    • No prodrome.

    • Lesions centripetal spread.

    • Start on trunk.

    • Superficial vesicles.

    • Lesions in different stages.

Etiology

  • Caused by Orthopoxvirus variola

  • Human vector only

  • Transmission via prolonged, inhalational contact with infected bodily fluid or contaminated material

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here